The Phospholipid Research Center located in Heidelberg, Germany was funded as a non-profit organisation and promotes a foundation for the use of phospholipids in pharmaceuticals.
The Phospholipid Research Center wants to extend the knowledge of phospholipids excipients for the improvement of bioavailability and tolerance of actives in oral, topical, pulmonary and parenteral Systems and their use as actives. It provides research funds for these investigations.
The Phospholipid Research Center is highly interested in oral systems with phospholipids to improve the resorption of active ingredients.
Scientists from all over the world are encouraged to submit research proposals covering these questions to apply for the funds for non-commercial uses.
Individual researchers and research groups are encouraged to submit research proposals (6-10 pages) written in English. The proposals should contain the specifications of costs and list all other funds.
Bio-Path Holdings Announces Dosing of First Patient in a Phase I Clinical Trial of Its Liposomal Grb-2 Cancer Drug Candidate
BUSINESS WIRE, July 29, 2010
The latest issues of our newsletter here...